drugset / Trial / NCT01653990
Moxifloxacin_QT Study in Chinese Healthy Volunteer
RandomizedCrossoverDouble-blindTreatment
Summary
A single-center, randomized, double-blinded, 2-way crossover, placebo-controlled study to assess the QTc interval after administration of single oral dose of 400mg Moxifloxacin in healthy Chinese subjects.
Timeline
- Start
- 2012-07
- Primary completion
- 2012-09
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Moxifloxacin | Small molecule | 400 mg | Oral |